Elevance Health: Should You Buy ELV Stock Ahead Of Its Upcoming Earnings?

Core Insights - Elevance Health (NYSE: ELV) is scheduled to report earnings on July 17, 2025, with analysts projecting earnings of $9.19 per share on revenue of $48.26 billion, compared to $10.12 per share and $43.22 billion in the same quarter last year [3][4] Group 1: Stock Performance and Historical Data - Over the last five years, Elevance Health has experienced positive one-day stock returns in 55% of cases following earnings announcements, with a median positive return of 2.7% and a maximum return of 7.7% [3][7] - In the past five years, there have been 18 earnings data points, resulting in 11 positive and 7 negative one-day returns, leading to a positive return rate of approximately 61%, which increases to 73% when considering the last three years [7] Group 2: Financial Metrics - Elevance Health currently has a market capitalization of $77 billion and has generated $183 billion in revenue over the past twelve months, with a net income of $5.9 billion [4] Group 3: Trading Strategies - Traders can adopt two primary strategies around earnings announcements: pre-earnings positioning and post-earnings positioning, evaluating immediate and medium-term returns to inform trading actions [6] - A lower-risk strategy involves understanding the correlation between short-term and medium-term returns following earnings, allowing traders to take positions based on the strongest correlations observed [8][9]